Short‐course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide-Reference-Cited by-同舟云学术

Short‐course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide

Published:2021-11 Issue:11 Volume:24 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Int AIDS Soc.

Author:

Liou Bo‐Huang¹^ORCID,Cheng Chih‐Ning²,Lin Ya‐Ting²,Lin Yu‐Jou³,Chuang Yu‐Chung⁴,Lin Kuan‐Yin⁴,Liu Wen‐Chun⁴,Lin Shu‐Wen²³⁵,Kuo Ching‐Hua²,Sun Hsin‐Yun⁴^ORCID,Hung Chien‐Ching⁴⁶^ORCID

Affiliation:

1. Department of Internal Medicine Hsinchu MacKay Memorial Hospital Hsinchu City Taiwan

2. School of Pharmacy National Taiwan University Taipei Taiwan

3. Department of Pharmacy National Taiwan University Hospital and National Taiwan University College of Medicine Taipei Taiwan

4. Department of Internal Medicine National Taiwan University Hospital and National Taiwan University College of Medicine Taipei Taiwan

5. Graduate Institute of Clinical Pharmacy National Taiwan University College of Medicine Taipei Taiwan

6. Department of Tropical Medicine and Parasitology National Taiwan University College of Medicine Taipei Taiwan

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25844

Reference28 articles.

1. World Health Organization. Global Tuberculosis Report 2020. Available at:https://www.who.int/publications/i/item/9789240013131. Accessed 1 February 2021.

2. World Health Organization. Latent TB infection: updated and consolidated guidelines for programmatic management. Available at:https://www.who.int/publications‐detail‐redirect/9789241550239. Accessed 1 February 2021.

3. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

4. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa

5. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical considerations and pharmacokinetic interactions between HIV and tuberculosis therapeutics;Expert Review of Clinical Pharmacology;2024-02-14

2. Daily Second-generation Integrase Strand Inhibitors and Short-course Tuberculosis Preventive Therapy: What More Do We Need to Know?;Clinical Infectious Diseases;2023-12-05

3. Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination With Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection Among People With Human Immunodeficiency Virus;Clinical Infectious Diseases;2023-12-05

4. Biktarvy for the treatment of HIV infection: Progress and prospects;Biochemical Pharmacology;2023-11

5. US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy;Clinical Infectious Diseases;2023-10-25